Skip to main content
Home
  • Connect with Us
  • News
  • Careers

Search form

  • About
    • About us
    • Emmes Brand Story
    • Our People
    • Emmes Leaders
    • Our Culture
    • Emmes by the Numbers
    • Clients
    • Emmes Locations
  • Therapeutic Areas
    • Emmes Therapeutic Areas
    • Vaccine Trials and Infectious Diseases
    • Ophthalmology
    • Hematology
    • Cell and Gene Therapy
    • Maternal and Child Health
    • Neuroscience
    • Oncology
    • Orphan & Rare Disease
    • Treatment of Substance Use Disorders
  • Services
    • Emmes Services Overview
    • Clinical Research Services
    • Biostatistics
    • Biomedical Data Science and Bioinformatics
    • Advantage eClinical Technology Platform
    • Clinical Data Management
    • Clinical Safety and Pharmacovigilance
    • Clinical Trial Management
    • FDA Regulatory
    • Medical Devices
    • Real-World Evidence & Data
  • Advantage eClinical
  • Experience and Publications
    • Our Work
    • Experience
    • Publications
    • Clinical Research Spotlight
  • Locations

Conversion to tacrolimus to ameliorate cyclosporine toxicities.

Go back to Publications
Publication Type
Journal Article
Year of Publication
1997
Authors
Anand R
Date Published
1997
  • Log in to post comments
  • Google Scholar
  • BibTeX

Headquarters
401 North Washington Street
Suite 700
Rockville, MD 20850

Phone
301.251.1161

    • About
      • About us
      • Emmes Brand Story
      • Our People
      • Emmes Leaders
      • Our Culture
      • Emmes by the Numbers
      • Clients
      • Emmes Locations
    • Therapeutic Areas
      • Emmes Therapeutic Areas
      • Vaccine Trials and Infectious Diseases
      • Ophthalmology
      • Hematology
      • Cell and Gene Therapy
      • Maternal and Child Health
      • Neuroscience
      • Oncology
      • Orphan & Rare Disease
      • Treatment of Substance Use Disorders
    • Services
      • Emmes Services Overview
      • Clinical Research Services
      • Biostatistics
      • Biomedical Data Science and Bioinformatics
      • Advantage eClinical Technology Platform
      • Clinical Data Management
      • Clinical Safety and Pharmacovigilance
      • Clinical Trial Management
      • FDA Regulatory
      • Medical Devices
      • Real-World Evidence & Data
    • Advantage eClinical
    • Experience and Publications
      • Our Work
      • Experience
      • Publications
      • Clinical Research Spotlight
    • Locations

Thank you for visiting our site and taking an interest in our products & services. Please feel free to contact us if you wish to receive more information.

For employment-related inquiries, please view our Careers Section.

Alternatively, please feel free to contact us via email using the form.

Contact Us

Thank you for your interest in working with Emmes.

Select the most appropriate location of Emmes.
Select "Yes" if this is regarding a Rare Disease study.
Select the most appropriate reason you are requesting follow-up from Emmes.
Your full name including your credentials if you prefer.
Should be a properly formatted email address where you would like to be contacted.
Please provide any additional information that may help us assist with your comments/request.
Twitter Linkedin
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • GDPR
  • Privacy Shield Policy
  • Purchasing Terms and Conditions
  • Vendor Disclosure Notice
Copyright © 2023, The Emmes Company, LLC
Back to Top